Member Spotlight: St. Peter’s Health Partners delivers monoclonal antibody therapy to COVID-19 patients
As hospitals across New York state diligently distribute COVID-19 vaccinations, expanding effective treatment for current coronavirus patients remains a key priority. On Dec. 3, Samaritan Hospital – Albany Memorial Campus (a member of St. Peter’s Health Partners) became the first healthcare institution in New York’s Capital Region to offer monoclonal antibody therapy, an FDA-authorized treatment for COVID-19.
Read our full story to learn more about this initiative and its results.
This story is just one of the many initiatives profiled on HANYS' Member Spotlight website that demonstrate how New York healthcare providers are investing in forward-looking initiatives that improve care quality and health outcomes.